A detailed history of Ferguson Wellman Capital Management, Inc transactions in Pfizer Inc stock. As of the latest transaction made, Ferguson Wellman Capital Management, Inc holds 58,558 shares of PFE stock, worth $1.61 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
58,558
Previous 58,475 0.14%
Holding current value
$1.61 Million
Previous $1.69 Million 0.12%
% of portfolio
0.03%
Previous 0.04%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$27.7 - $31.39 $2,299 - $2,605
83 Added 0.14%
58,558 $1.69 Million
Q3 2024

Oct 18, 2024

SELL
$27.7 - $31.39 $24,569 - $27,842
-887 Reduced 1.49%
58,475 $1.69 Million
Q2 2024

Jul 16, 2024

SELL
$25.26 - $29.6 $490,801 - $575,128
-19,430 Reduced 24.66%
59,362 $1.66 Million
Q1 2024

Apr 09, 2024

SELL
$25.89 - $29.73 $209,165 - $240,188
-8,079 Reduced 9.3%
78,792 $2.19 Million
Q4 2023

Jan 11, 2024

SELL
$26.13 - $33.94 $13.8 Million - $17.9 Million
-526,881 Reduced 85.85%
86,871 $2.5 Million
Q3 2023

Oct 12, 2023

SELL
$32.09 - $37.51 $848,427 - $991,726
-26,439 Reduced 4.13%
613,752 $20.4 Million
Q2 2023

Jul 11, 2023

SELL
$36.12 - $41.79 $1.06 Million - $1.23 Million
-29,323 Reduced 4.38%
640,191 $23.5 Million
Q1 2023

Apr 20, 2023

SELL
$39.39 - $51.28 $28.1 Million - $36.6 Million
-713,989 Reduced 51.61%
669,514 $27.3 Million
Q4 2022

Jan 13, 2023

BUY
$41.75 - $54.5 $30 Million - $39.2 Million
719,540 Added 108.37%
1,383,503 $70.9 Million
Q3 2022

Oct 17, 2022

BUY
$43.76 - $53.42 $530,765 - $647,931
12,129 Added 1.86%
663,963 $29.1 Million
Q2 2022

Jul 14, 2022

SELL
$46.53 - $55.17 $13.3 Million - $15.7 Million
-285,248 Reduced 30.44%
651,834 $34.2 Million
Q1 2022

Apr 14, 2022

SELL
$45.75 - $56.69 $739,731 - $916,620
-16,169 Reduced 1.7%
937,082 $48.5 Million
Q4 2021

Jan 10, 2022

BUY
$41.32 - $61.25 $1.97 Million - $2.93 Million
47,761 Added 5.27%
953,251 $56.3 Million
Q3 2021

Oct 22, 2021

BUY
$39.25 - $50.42 $15.4 Million - $19.8 Million
393,460 Added 76.84%
905,490 $38.9 Million
Q2 2021

Jul 12, 2021

BUY
$35.91 - $40.68 $14.5 Million - $16.4 Million
402,692 Added 368.3%
512,030 $20.1 Million
Q1 2021

Apr 26, 2021

SELL
$33.49 - $37.77 $507,340 - $572,177
-15,149 Reduced 12.17%
109,338 $3.96 Million
Q4 2020

Feb 04, 2021

SELL
$33.47 - $42.56 $130,131 - $165,473
-3,888 Reduced 3.03%
124,487 $4.58 Million
Q3 2020

Oct 13, 2020

SELL
$31.75 - $37.25 $57,626 - $67,608
-1,815 Reduced 1.39%
128,375 $4.71 Million
Q2 2020

Aug 04, 2020

SELL
$30.12 - $36.54 $46,264 - $56,125
-1,536 Reduced 1.17%
130,190 $4.26 Million
Q1 2020

Apr 21, 2020

SELL
$27.03 - $38.62 $153,476 - $219,284
-5,678 Reduced 4.13%
131,726 $4.3 Million
Q4 2019

Jan 24, 2020

SELL
$32.92 - $37.36 $12,772 - $14,495
-388 Reduced 0.28%
137,404 $5.38 Million
Q3 2019

Oct 15, 2019

BUY
$32.49 - $42.13 $664,550 - $861,727
20,454 Added 17.43%
137,792 $4.95 Million
Q2 2019

Jul 16, 2019

SELL
$36.98 - $41.52 $5.41 Million - $6.08 Million
-146,323 Reduced 55.5%
117,338 $5.08 Million
Q1 2019

Apr 11, 2019

BUY
$37.5 - $41.2 $57,300 - $62,953
1,528 Added 0.58%
263,661 $11.2 Million
Q4 2018

Jan 16, 2019

SELL
$38.47 - $43.86 $164,959 - $188,071
-4,288 Reduced 1.61%
262,133 $10.9 Million
Q3 2018

Oct 25, 2018

BUY
$34.47 - $41.81 $5,549 - $6,731
161 Added 0.06%
266,421 $11.7 Million
Q2 2018

Aug 10, 2018

BUY
$32.98 - $35.16 $162,624 - $173,373
4,931 Added 1.89%
266,260 $9.66 Million
Q1 2018

Apr 09, 2018

BUY
$31.91 - $37.02 $216,956 - $251,698
6,799 Added 2.67%
261,329 $9.28 Million
Q4 2017

Jan 24, 2018

BUY
$33.26 - $35.29 $49,258 - $52,264
1,481 Added 0.59%
254,530 $9.22 Million
Q3 2017

Oct 11, 2017

BUY
$31.0 - $34.15 $7.84 Million - $8.64 Million
253,049
253,049 $9.03 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ferguson Wellman Capital Management, Inc Portfolio

Follow Ferguson Wellman Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ferguson Wellman Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ferguson Wellman Capital Management, Inc with notifications on news.